We're excited that at this year’s American Brachytherapy Society (ABS) Meeting, Prof. Keisari was awarded the Best Oral Presentation...

Alpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy, Alpha DaRT, announced today that it has obtained ISO...

Tel Aviv, Israel, March 26, 2019 – Alpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy, Alpha DaRT, announced...

Radiation therapy, the use of high-energy particles or waves, such as x-rays, gamma rays, electrons, or protons, has long been used to...

10 companies were selected under the healthcare category and 4 were from Israel, including Alpha Tau Medical.

#CancerBuster Now going into clinical trials for specific types of cancer, Alpha Tau’s technology shows potential for treating any solid...

Alpha Tau Medical today announced that it will present at Biotech Showcase™ 2019, to be held January 7–9, during the JP Morgan Healthcare...

An Israeli medical technology company is set to begin testing its new radiation cancer therapy in leading medical centers in Italy. The...

Trials will investigate the efficacy of its breakthrough cancer treatment, Alpha DaRT, in Squamous Cell Carcinoma (SCC) of the Skin, and...

Cancer is the most devastating chronic disease affecting humankind. More than 1 out of 3 people in the United States will have cancer...